Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3977087 | Brachytherapy | 2011 | 5 Pages |
Abstract
Combination treatment using brachytherapy and EBRT is well tolerated, with acceptable overall survival and bRFS rates and should be considered a standard treatment option for patients. Hormones should be considered for high-risk patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Gregory J. Kubicek, Marco Naguib, Sandy Redfield, Nola Grayback, Sam I. Brown,